Pharmaceutical Storage Management and Its Impact on Medication Obsolescence: A Case Study of Nizam Farma Pharmacy in 2025
DOI:
https://doi.org/10.58511/v3i1.10214Keywords:
Dosage forms, expiry date, FEFO, pharmacy, storage managementAbstract
This evaluative study investigates the pharmaceutical storage management system at Nizam Farma Pharmacy to determine its degree of adherence to the Indonesian Ministry of Health (MOH) Regulation No. 73 of 2016 and the associated technical guidelines. A descriptive quantitative observational design was employed, utilizing a comprehensive 23-variable checklist for direct-site auditing. In addition to observational data, a secondary analysis of the facility’s 2024 medication expiration logs was conducted to identify obsolescence profiles of the medications. The pharmacy attained a compliance index of 0.80, correlating to the "Very Good" qualitative benchmark. Despite this, critical systemic vulnerabilities were identified in four variables: the absence of dedicated vaccine storage, lack of backup power infrastructure (generator), inconsistent routine inspections, and failure to implement specialized labeling and physical distancing for LASA (Look Alike Sound Alike) medications. Analysis of expired stock revealed that solid dosage forms accounted for 72% of losses, with Prescription Drugs (Obat Keras) representing 55% of the total. Furthermore, 80% of the expired items were categorized as "Slow-Moving" inventory. While Nizam Farma exhibits high foundational compliance, the reliance on an alphabetical-first in, first out (FIFO) hybrid rather than a strict First Expired, First Out (FEFO) system, coupled with branding proliferation in vitamins and antibiotics, serves as the primary driver of obsolescence. The remediation of safety protocols and cold-chain resilience is imperative.
References
[1] W. K. Hapsari, N. Elah, M. N. Sulaiman R, A. Aryadhi, Y. A. H. Gobel, and P. B. Sura, “ApoLink: Connect Directly with Pharmacists to Get the Best Healthcare Services,” Journal of Security, Computer, Information, Embedded, Network, and Intelligence System, pp. 53–61, 2024, doi: 10.61220/scientist.v2i2.20241.
[2] T. Zarkua, I. Kekelidze, and M. Beridze, “The Role of the Pharmacıst in the Healthcare System,” Experımental & Clınıcal Medıcıne Georgıa, 2025, doi: 10.52340/jecm.2025.02.18.
[3] J. I. P P A, K. Kuswiyanto, M. F. Abdillah, N. Hidayat, and Y. Prastyo, “Literature Review: Comparative Analysis of FIFO and FEFO Management Methods,” Engineering and Technology Journal, vol. 10, no. 06, 2025, doi: 10.47191/etj/v10i06.16.
[4] H. Mursiti, G. M. E. B. P. Mesias, and P. Indrayudha, “Implementation of Drug Administration with High Awareness (LASA/ Look Alike Sound Alike and High Alert) for Patient Safety at Pharmacies in Surakarta,” Pharmacon: Jurnal Farmasi Indonesia, vol. 19, no. 2, pp. 197–202, 2022, doi: 10.23917/pharmacon.v19i2.20019.
[5] R. Sharma, “The value of the cold chain system,” Zenodo (CERN European Organization for Nuclear Research), 2022, doi: 10.5281/zenodo.7226918.
[6] I. Peate, “Principles of medicine management: safe practice,” British Journal of Healthcare Assistants, vol. 18, no. 10, pp. 392–397, 2024, doi: 10.12968/bjha.2024.18.10.392.
[7] V. Chandel, H. P. Singh, N. Rarokar, and K. Wadher, “Stabilization of the pharmaceutical finished dosages form by using various techniques,” Journal of Drug Delivery and Therapeutics, vol. 14, no. 6, pp. 44–50, 2024, doi: 10.22270/jddt.v14i6.6619.
[8] M. Kabir, M. Rana, and A. Debnath, “The Role of Quality Assurance in Accelerating Pharmaceutical Research and Development: Strategies for Ensuring Regulatory Compliance and Product Integrity,” Journal of Angiotherapy, vol. 8, no. 12, pp. 1–11, 2024, doi: 10.25163/angiotherapy.81210102.
[9] P. Antasia and D. D. Y. Tarina, “Legal Protection For Consumers Related To The Circulation Of Hard Drugs By Unlicensed Drug Stores In Indonesia,” Unram Law Review, vol. 8, no. 2, 2024, doi: 10.29303/ulrev.v8i2.383.
[10] K. M. Niehoff et al., “Hospital at home: Development of pharmacy services,” American Journal of Health-System Pharmacy, vol. 79, no. 22, pp. 1981–1987, 2022, doi: 10.1093/ajhp/zxac225.
[11] F. Alnahas, P. Yeboah, L. Fliedel, A. Y. Abdin, and K. Alhareth, “Expired Medication: Societal, Regulatory and Ethical Aspects of a Wasted Opportunity.,” Int. J. Environ. Res. Public Health, vol. 17, no. 3, p. 787, 2020, doi: 10.3390/ijerph17030787.
[12] M. Adedayo, “Evaluating the Influence of Regulatory Compliance on Operational Risks in Healthcare,” International Journal of Modern Risk Management, vol. 1, no. 1, pp. 12–22, 2023, doi: 10.47604/ijmrm.2094.
[13] P. Dunbar, L. Keyes, and J. P. Browne, “Determinants of regulatory compliance in health and social care services: a systematic review using the Consolidated Framework for Implementation Research,” 2022, Medrxiv. doi: 10.1101/2022.11.14.22282145.
[14] P. Benedek and F. Bognár, “Compliance Risk Assessment – Results of a Comprehensive Literature Review,” Acta Polytechnica Hungarica, vol. 21, no. 6, pp. 243–262, 2024, doi: 10.12700/aph.21.6.2024.6.13.
[15] J. Nind, A. Smith, S. Scahill, and C. A. Marra, “A Systematic Review of Independent and Chain Pharmacies Effects on Medication Adherence.,” Pharmacy, vol. 10, no. 5, p. 124, 2022, doi: 10.3390/pharmacy10050124.
[16] M. Leena Thakare, M. Gaurav Mate, M. Gauri Gharat, and M. Priyanka Sawant, “Inventory Management: Assocıated Costs, Functıons, Factors, And Conclusıons,” International Journal of Novel Research and Development, vol. 11, no. 1, 2026, doi: 10.56975/ijnrd.v11i1.311502.
[17] V. K. Srivastava and A. Nand, “Application and technique of inventory control theory in pharmaceutical sciences,” International Journal of Operational Research, vol. 47, no. 1, p. 109, 2023, doi: 10.1504/ijor.2023.130855.
[18] M. Selpiyana, A. Fergina, and I. Yustiana, “Web-Based Drug Inventory System with FIFO Method and SCM Approach at Risa Farma Pharmacy,” bit-Tech, vol. 8, no. 2, pp. 1446–1454, 2025, doi: 10.32877/bt.v8i2.2951.
